Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine <i>N</i>-methyltransferase.

In Pemt +/+ mice, the reduction in weight gain on ezetimibe seemed to be accompanied by a slightly improved glucose tolerance; however, this did not reach statistical significance ( Fig. 1E, F ).

also in 111,027 other papers